Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period.

Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS.

Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and unvested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS.

The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts):


	Fiscal Quarter Ended				Fiscal Year-To-Date Ended
	June 26, 2026		June 27, 2025		June 26, 2026		June 27, 2025
Numerator:
Net income attributable to Dolby Laboratories, Inc.	$	28,602	$	46,071	$	176,844	$	205,686

Denominator:
Weighted-average shares outstanding—basic	94,242		95,897		94,975		95,947
Potential common shares from options to purchase common stock	16		316		32		395
Potential common shares from restricted stock units	230		660		805		1,147
Potential common shares from employee stock purchase plan	30		27		47		48
Weighted-average shares outstanding—diluted	94,518		96,900		95,859		97,537

Net income per share attributable to Dolby Laboratories, Inc.:
Basic	$	0.30	$	0.48	$	1.86	$	2.14
Diluted	$	0.30	$	0.48	$	1.84	$	2.11

Antidilutive awards excluded from calculation:
Stock options	3,421		1,516		2,934		1,425
Restricted stock units	1,785		41		31		6
Employee stock purchase plan	21		6		3		1